Erbitux Gets C-Code Reimbursement; Waits For Green Light On J-Code
This article was originally published in The Pink Sheet Daily
Executive Summary
ImClone has not seen "obstacles" to reimbursement across all patients. During the quarter, Erbitux generated $17.5 mil. in sales.